Growth differentiation factor‐15 for prediction of bleeding in cancer patients

BACKGROUND: Growth differentiation factor‐15 (GDF‐15) is a strong predictor for bleeding in patients with atrial fibrillation, but there are no data on cardiovascular outcomes for this biomarker in cancer patients. Bleeding risk assessment is important in cancer patients when considering primary thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Frits I., Bosch, Floris T. M., Carrier, Marc, Mallick, Ranjeeta, Middeldorp, Saskia, van Es, Nick, Kamphuisen, Pieter Willem, Wells, Phill S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298353/
https://www.ncbi.nlm.nih.gov/pubmed/34662498
http://dx.doi.org/10.1111/jth.15559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298353/
https://www.ncbi.nlm.nih.gov/pubmed/34662498
http://dx.doi.org/10.1111/jth.15559

Ejemplares similares